Executive Medical Director

Global Clinical Development Lead (Executive Medical Director) – Hematologic Malignancies West Coast Preferred Meet has been retained by a clinical stage biotech at the forefront of targeted protein degradation seeking an experienced physician leader to serve as Global Clinical Development Lead for a flagship hematology‑oncology program approaching a pivotal stage of development This is a highly visible leadership opportunity for a physician who wants to play a central role in shaping the global development strategy for a potentially practice‑changing therapy in B‑cell malignancies. Reporting directly into senior clinical leadership, you will drive the overall clinical development plan, provide medical leadership across late‑stage studies, and serve as a key voice with regulators, investigators, and external experts The successful candidate will join an organization that has established one of the industry's most differentiated drug discovery platforms, generated multiple strategic pharmaceutical partnerships, and is now advancing a growing portfolio of wholly owned clinical programs. Key responsibilities include Global leadership responsibility for a late‑stage hematology program with registrational ambitions Opportunity to influence regulatory strategy, study design, and lifecycle planning Direct engagement with leading academic investigators and KOLs across hematologic malignancies Exposure to a clinically validated targeted protein degradation platform with significant long‑term pipeline potential Executive‑level visibility and partnership with senior R&D leadership We are particularly interested in speaking with physicians who bring MD with board certification in Hematology, Oncology, or Hematology‑Oncology Prior experience leading global clinical development programs in hematologic malignancies Experience supporting pivotal and/or registrational studies Strong scientific credibility within the leukemia and lymphoma community Ability to operate strategically while leading cross‑functional execution across global teams This is an opportunity to join a well‑capitalized organization at an inflection point, where clinical execution, scientific innovation, and long‑term pipeline potential intersect. #J-18808-Ljbffr